Fairmount Funds Management LLC

SEC CIK: 0001802528
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

VRDN holding history

Viridian Therapeutics, Inc. in every 13F filed by Fairmount Funds Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRDN overview All 13F holders of VRDN Full Q2 2026 holdings

Shares (Q2 2026): 5,090,928
Value: $93.5M
% of portfolio: 6.2%
Quarters held: 22; Since Q1 2021

Holdings of VRDN by Fairmount Funds Management LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	5,090,928	$93.5M	6.2%	+1,176,470+30.1%	Added	Holders
Q1 2026	3,914,458	$76.6M	5.5%	00.0%	Unchanged	Holders
Q4 2025	3,914,458	$121.8M	9.3%	+454,545+13.1%	Added	Holders
Q3 2025	3,459,913	$74.7M	6.7%	00.0%	Unchanged	Holders
Q2 2025	3,459,913	$48.4M	6.3%	+14,100+0.4%	Added	Holders
Q1 2025	3,445,813	$46.4M	7.2%	00.0%	Unchanged	Holders
Q4 2024	3,445,813	$66.1M	6.6%	00.0%	Unchanged	Holders
Q3 2024	3,445,813	$78.4M	6.4%	+1,600,000+86.7%	Added	Holders
Q2 2024	1,845,813	$24.0M	2.7%	00.0%	Unchanged	Holders
Q1 2024	1,845,813	$32.3M	3.5%	+476,190+34.8%	Added	Holders
Q4 2023	1,369,623	$29.8M	3.2%	00.0%	Unchanged	Holders
Q3 2023	1,369,623	$21.0M	2.5%	00.0%	Unchanged	Holders
Q2 2023	1,369,623	$32.6M	4.6%	00.0%	Unchanged	Holders
Q1 2023	1,369,623	$34.8M	6.0%	00.0%	Unchanged	Holders
Q4 2022	1,369,623	$40.0M	6.3%	00.0%	Unchanged	Holders
Q3 2022	1,369,623	$28.1M	5.2%	+425,531+45.1%	Added	Holders
Q2 2022	944,092	$10.9M	2.5%	00.0%	Unchanged	Holders
Q1 2022	944,092	$17.5M	4.1%	00.0%	Unchanged	Holders
Q4 2021	944,092	$18.7M	6.2%	00.0%	Unchanged	Holders
Q3 2021	944,092	$15.5M	5.6%	+909,000+2,590.3%	Added	Holders
Q2 2021	35,092	$642.0K	0.3%	00.0%	Unchanged	Holders
Q1 2021	35,092	$581.0K	0.2%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.